Welcome to our dedicated page for Oxbridge Re Hldg SEC filings (Ticker: OXBRW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Oxbridge Re Holdings Limited Warrant expiring 3/26/2029 (NASDAQ: OXBRW) is linked to Oxbridge Re Holdings Limited, a Cayman Islands–incorporated company whose ordinary shares trade under the symbol OXBR. On Stock Titan’s SEC filings page for OXBRW, you can review regulatory documents filed by Oxbridge Re that relate to both its equity and its listed warrants, including OXBRW.
Oxbridge Re’s SEC filings provide detail on its activities as a property and casualty reinsurer and as a participant in tokenized Real-World Assets (RWAs). In Forms 8-K, the company has disclosed items such as an Equity Distribution Agreement for at-the-market offerings of ordinary shares, the adoption of the Oxbridge Re Holdings Limited 2025 Omnibus Incentive Plan, and amendments to its memorandum and articles of association to increase authorized share capital. These filings also describe executive employment agreements and corporate action, change of control, and performance agreements that grant restricted share units upon certain triggering events.
Through its Definitive Proxy Statement (DEF 14A), Oxbridge Re outlines proposals presented to shareholders, including increases in authorized share capital and approval of the 2025 Omnibus Incentive Plan. Together, these documents help investors understand the company’s capital structure, governance framework, and potential sources of dilution, all of which are relevant when evaluating the underlying ordinary shares and derivative securities such as OXBRW.
On Stock Titan, SEC filings for Oxbridge Re are supplemented with AI-powered summaries that explain key points in accessible language. Investors can quickly see the main terms of material agreements, equity plans, and capital-raising programs without reading every page of the original documents. The filings page updates as new reports are posted to EDGAR, giving users a current view of Oxbridge Re’s regulatory disclosures, including 8-Ks, proxy statements, and other filings that may affect the value and risk profile of the OXBRW warrant and the underlying OXBR shares.
Oxbridge Re Holdings Limited entered into a short-term financing agreement, borrowing
If the company defaults, the interest rate increases to 36% per year, or the maximum allowed by law. The loan can be repaid early without penalty, and is secured by a lien on substantially all of the company’s assets. Oxbridge Re plans to use the funds for working capital and general corporate purposes.
Oxbridge Re Holdings Limited announced that its indirect subsidiary SurancePlus Inc. has commenced a private offering of Participation Shares represented by digital tokens under a 3‑year Participation Share Investment Contract.
At launch, up to 2,000,000 Participation Shares labelled “T20‑2027” (balanced yield) and “T42‑2027” (high yield) will be offered at an initial price of $10.00 per Participation Share, with discounts of up to 5% for larger investments.
Net proceeds will be used by SurancePlus to purchase participating notes of affiliated reinsurer Oxbridge Re NS, whose note proceeds will be invested in collateralized reinsurance contracts. Holders are entitled to an Investor Final Return based on the initial price plus a share of net underwriting profits, with preferred return hurdles of 8% and 16% annualized for the balanced and high yield tranches, respectively.
The securities are being sold as unregistered offerings under SEC Rule 506(c) to accredited investors in the United States and under Regulation S to non‑U.S. persons, and this disclosure is furnished under Regulation FD rather than filed.
Allan S. Martin, a director of Oxbridge Re Holdings Ltd (symbol: OXBRW), reported a sale of ordinary shares on 09/16/2025. The Form 4 shows 4,328 shares sold at $2.4505 per share, with the filing signed by an attorney-in-fact on 09/19/2025. Following the reported transaction, Mr. Martin directly holds 216,803 ordinary shares (jointly with his wife) and indirectly holds 68,770 shares via Fleur de Lis Partners, LLLP and 102,223 shares via the Martin Family Foundation, Inc., with disclaimers that he disclaims beneficial ownership of the indirectly held shares except to the extent of his pecuniary interest.
Oxbridge Re Holdings reported that shareholders approved a major increase in authorized share capital from 50,000,000 to 500,000,000 ordinary shares, creating an additional 450,000,000 shares. Shareholders also approved a new 2025 Omnibus Incentive Plan reserving 1,569,514 ordinary shares for equity awards, with potential annual increases tied to up to 5% of shares outstanding through 2035.
The company entered amended employment agreements with CEO Jay Madhu and CFO Wrendon Timothy, setting base salaries of $390,000 and $245,000 effective January 1, 2026, plus automatic salary increases if the company completes financings or strategic transactions of at least $100 million. Each executive will receive annual restricted share grants (40,000 for Mr. Madhu and 25,000 for Mr. Timothy) and M&A transaction bonuses based on transaction value. The board also approved change-of-control and performance agreements granting fully vested RSUs upon certain corporate transactions or revenue milestones, with these awards treated as unregistered private offerings under the Securities Act.
Allan S. Martin, a director of Oxbridge Re Holdings Ltd (OXBR), reported sales of ordinary shares on 08/27/2025. The Form 4 shows two sell transactions: 3,449 shares sold at $2.3948 and 6,551 shares sold at $2.3812. After those transactions the filing reports beneficial ownership figures of 227,682 and 221,131 (reported on separate lines) for the direct holdings shown. The filing also discloses 68,770 ordinary shares held indirectly by Fleur de Lis Partners, LLLP and 102,223 ordinary shares held indirectly by the Martin Family Foundation, Inc., with Mr. Martin described as having voting and/or investment power over those entities' holdings. The form is signed by an attorney-in-fact on 08/29/2025.
Armistice Capital, LLC and Steven Boyd report collective beneficial ownership of 395,792 ordinary shares of Oxbridge Re Holdings Ltd, representing 4.99% of the class. The shares are held directly by Armistice Capital Master Fund Ltd., for which Armistice Capital serves as investment manager; Armistice Capital and Mr. Boyd each report shared voting and shared dispositive power over these shares and report no sole voting or dispositive power. The filing states the securities are held in the ordinary course of business and were not acquired to effect a change of control. The Master Fund disclaims direct beneficial ownership to the extent it lacks voting or dispositive power under its investment management agreement.